ACELYRIN, Inc.: directors' dealings · United States · SEC (Form 4) Explore the full management transaction log of ACELYRIN, Inc., a listed issuer based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was reported on 23 May 2025 (Disposition). Among the most active insiders: Kim Mina. Every trade is accessible without an account.
€307,366
15 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 23 May 2025
All Executives43 Thresholds0 Prospectus0 Other0
Declarations 43 total
● Director · Executives · 21 May 2025
14,675 shares Common Stock SEC:0001962918-25-000056:0
● Director · Executives · 21 May 2025
50,000 shares Common Stock SEC:0001962918-25-000058:0
◆ Chief Executive Officer · Executives · 21 May 2025
89,526 shares Common Stock SEC:0001962918-25-000068:0
● Chief Medical Officer · Executives · 21 May 2025
121,789 shares Common Stock SEC:0001962918-25-000060:0
● Director · Executives · 21 May 2025
9,334,735 shares 0Common Stock, par value $0.00001 per share ("Common Stock") SEC:0000902664-25-002533:0
● Director · Executives · 21 May 2025
2,999 shares Common Stock SEC:0001962918-25-000052:0
● Chief Legal Officer · Executives · 21 May 2025
121,587 shares Common Stock SEC:0001962918-25-000064:0
● Director · Executives · 21 May 2025
15,000 shares Common Stock SEC:0001962918-25-000054:0
● Director · Executives · 21 May 2025
60,000 shares Common Stock SEC:0001962918-25-000062:0
◆ Chief Executive Officer · Executives · 15 May 2025
30,851 shares 0Common Stock SEC:0001962918-25-000038:0
▼ Chief Medical Officer · Executives · 17 Mar 2025
3,211 shares @ US$2.744 100.0% of flow Common Stock SEC:0001962918-25-000026:0
▼ Chief Executive Officer · Executives · 17 Mar 2025
17,986 shares @ US$2.744 26.8% of flow Common Stock SEC:0001962918-25-000031:0
▼ Chief Legal Officer · Executives · 17 Mar 2025
3,913 shares @ US$2.744 100.0% of flow Common Stock SEC:0001962918-25-000029:0
◆ Chief Medical Officer · Executives · 23 Jan 2025
125,000 shares 0Common Stock SEC:0001962918-25-000009:0
◆ Chief Legal Officer · Executives · 23 Jan 2025
125,000 shares 0Common Stock SEC:0001962918-25-000005:0
◆ Chief Executive Officer · Executives · 23 Jan 2025
575,000 shares 0Common Stock SEC:0001962918-25-000007:0
▼ Director · Executives · 17 Jul 2024
1 shares @ US$6.86 0.0% of flow Common Stock SEC:0001962918-24-000099:0
● Chief Executive Officer · Executives · 15 May 2024
10,230 shares @ US$4.47 24.8% of flow Common Stock SEC:0001962918-24-000061:0
● Chief Operating Officer · Executives · 15 May 2024
10,298 shares @ US$4.47 100.0% of flow Common Stock SEC:0001962918-24-000063:0
● CLO & Head of People · Executives · 15 May 2024
921 shares @ US$4.47 100.0% of flow Common Stock SEC:0001962918-24-000060:0
▼ Chief Executive Officer · Executives · 1 Apr 2024
9,961 shares @ US$6.6283 25.2% of flow Common Stock SEC:0001962918-24-000036:0
▼ Chief Executive Officer · Executives · 20 Feb 2024
15,701 shares @ US$7.6048 45.4% of flow Common Stock SEC:0001962918-24-000015:0
▼ Chief Executive Officer · Executives · 2 Jan 2024
10,691 shares @ US$7.407 29.4% of flow Common Stock SEC:0001962918-24-000002:0
● Director · Executives · 4 Oct 2023
14,675 shares 0Common Stock SEC:0001962918-23-000037:0
● Chief Financial Officer · Executives · 4 Oct 2023
40,763 shares 0Common Stock SEC:0001962918-23-000034:0
25 of 43 declarations
Load more (18 remaining)